Aurobindo pharma looks to continue its uptrend
1. Cup and handle breakout and retest
2. Price surge from long-term trendline
3. 20-50 EMA support
4. Rising EPS and Sales
2. Price surge from long-term trendline
3. 20-50 EMA support
4. Rising EPS and Sales
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.